Research LettersCarriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
References (5)
- et al.
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
Vaccine
(2001) - et al.
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
Lancet
(2001)
Cited by (397)
Bacterial Meningitis
2023, Manson's Tropical Diseases, Fourth EditionEffect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial
2022, The Lancet MicrobeCitation Excerpt :Pharyngeal colonisation with the pathogen Neisseria meningitidis occurs in approximately 10% of the population and is a prerequisite for invasive meningococcal disease.1 Although glycoconjugate meningococcal vaccines have markedly reduced the prevalence of invasive meningococcal disease, largely owing to the induction of herd protection through population-level reduction of N meningitidis colonisation,2,3 protein-based serogroup B vaccines (4CMenB and MenB-FHbp) do not reduce colonisation by serogroup B N meningitidis and are therefore unlikely to provide herd protection.4–6 Evidence before this study
Meningococcal disease in North America: Updates from the Global Meningococcal Initiative
2022, Journal of InfectionImpact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
2022, Clinical Microbiology and InfectionCitation Excerpt :An infant-only ‘2 + 1’ schedule of 4CMenB (Bexsero, GSK) commenced in September 2015 [13], which was not anticipated to impact on meningococcal carriage [14]. The UK Meningococcal Carriage (UKMenCar1-4) surveys demonstrated the impact of herd protection from the MCC vaccine and highlighted behaviours that increase the risk of meningococcal carriage and transmission [4,15,16]. UKMenCar4 was conducted in 2014 and 2015 just prior to the introduction of the MenACWY vaccination programme.
Member listed at end of letter